Skip navigation

Refine by Type

  • All Results (12)
  • Health Topics
  •  External Health Links (12)
  • Drugs and Supplements
  • Medical Encyclopedia
  • Videos and Tutorials
  • News
  • MedlinePlus Magazine
  • Other Resources
  • Multiple Languages

Refine by Keyword

Results 1 - 10 of 12 for IBRITUMOMAB TIUXETAN
  1. Drugs Approved for Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    ... Dacarbazine) Folex (Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Ibritumomab Tiuxetan Ibrutinib Idelalisib Imbruvica (Ibrutinib) Intron A (Recombinant Interferon ...
  2. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Topotecan Hydrochloride) Hyper-CVAD Back to Top I Ibritumomab Tiuxetan Ibrutinib ICE Iclusig (Ponatinib Hydrochloride) Idelalisib Ifex (Ifosfamide) ... Ipilimumab) Z Zaltrap (Ziv-Aflibercept) Zelboraf (Vemurafenib) Zevalin ... (Dexrazoxane Hydrochloride) Ziv-Aflibercept Zoladex (Goserelin Acetate) ...
  3. Radioimmunotherapy (Radiological Society of North America) (American College of Radiology)  
    ... two agents being used today are Yttrium-90 Ibritumomab Tiuxetan ( Zevalin ®) and Iodine-131 Tositumomab ( Bexxar ®) for radioimmunotherapy. ... special precautions will be needed for Yttrium-90 Ibritumomab Tiuxetan (Zevalin®). top of page • How it's performed RIT ...
  4. List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012 (Centers for Disease Control and Prevention) - PDF  
    ... 2,3,4,5 10:00 Antineoplastic agents Ibritumomab tiuxetan 3 10:00 Antineoplastic agents Idarubicin 1,2, ...
  5. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... the CD25 component of the interleukin-2 receptor. Ibritumomab tiuxetan (Zevalin ® ) is a radioimmunotherapy (conjugated monoclonal antibody) approved ...
  6. Mantle Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... iodine I-131-tositumomab (Bexxar®) and Yttrium-90 ibritumomab tiuxetan (Zevalin®), both given intravenously (IV), are FDA approved ...
  7. Marginal Zone Lymphoma (Lymphoma Research Foundation) - PDF  
    ... growing lymphomas, including: • B-cell receptor signaling blockers • Ibritumomab tiuxetan (Zevalin) It is critical to remember that today’s ...
  8. Radiation Therapy for Cancer From the National Institutes of Health (National Cancer Institute)  
    ... and killing tumor cells. For example: The drug ibritumomab tiuxetan (Zevalin®) has been approved by the Food and ...
  9. Travelers' Health: Immunocompromised Travelers (Centers for Disease Control and Prevention)  
    ... Copaxone Immunomodulatory; target unknown Golimumab Simponi TNF blocker Ibritumomab tiuxetan Zevalin CD20 with radioisotope Imatinib mesylate Gleevec, STI ...
  10. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... LDK378/Zykadia) Lymphoma: Tositumomab and 131I-tositumomab (Bexxar®) , Ibritumomab tiuxetan (Zevalin®) , Denileukin diftitox (Ontak®) , Brentuximab vedotin (Adcetris®) , Rituximab ( ...
previous · 1 · 2 · next